05:29 PM EST, 11/27/2024 (MT Newswires) -- Yvonne Greenstreet, Director, Chief Executive Officer, on Nov. 25 and Nov. 26, sold 5,219 shares in Alnylam Pharmaceuticals ( ALNY ) for $1,309,853. Following the Form 4 filing with the SEC, Greenstreet has control over a total of 79,287 shares of the company, with 78,880 shares held directly and 407 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1178670/000173527624000108/xslF345X05/edgardoc.xml